Viewing StudyNCT04488705



Ignite Creation Date: 2024-05-06 @ 2:59 PM
Last Modification Date: 2024-10-26 @ 1:41 PM
Study NCT ID: NCT04488705
Status: COMPLETED
Last Update Posted: 2021-05-21
First Post: 2020-07-23

Brief Title: A First in Human Study to Evaluate the Safety Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects
Sponsor: Enterprise Therapeutics Ltd
Organization: Enterprise Therapeutics Ltd

Conditions & Keywords Data

Conditions:
Name
Healthy
Keywords:
Name View
Cystic fibrosis View